Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder

Depression is a significant cause of morbidity and mortality globally. Although various pharmacologic options exist for depression, treatments are limited by delayed or incomplete therapeutic response, low rates of remission, and adverse effects necessitating effective, fast-acting, and better toler...

Descripción completa

Detalles Bibliográficos
Autores principales: McCarthy, Brian, Bunn, Hannah, Santalucia, Morgan, Wilmouth, Charlotte, Muzyk, Andrew, Smith, Colin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591164/
https://www.ncbi.nlm.nih.gov/pubmed/37859435
http://dx.doi.org/10.9758/cpn.23.1081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591164/
https://www.ncbi.nlm.nih.gov/pubmed/37859435
http://dx.doi.org/10.9758/cpn.23.1081

Ejemplares similares